
Koppers (KOP) Stock Forecast & Price Target
Koppers (KOP) Analyst Ratings
Bulls say
Koppers Holdings Inc. has demonstrated strong financial performance, with a substantial 78.1% increase in adjusted EBITDA, reaching $5.04 million, highlighting effective operating leverage. The gross profit also rose by 43.7% to $12.2 million, supported by a higher gross margin of 56.3%, as the company saw an increased contribution from its Pharma segment. Additionally, the company is forecasted to achieve a revenue increase of 11% in its Performance Chemicals segment for 2026, driven by market share expansion, reinforcing a positive long-term outlook.
Bears say
Koppers Holdings Inc reported a significant decline in consolidated sales, with a decrease of 10% in 2025, resulting in revenues of $1.9 billion compared to $2.1 billion the previous year, indicating a continued downward trend. In Q4/25, net sales for the Railroad and Utility Products and Services segment decreased by 3.2% year-over-year, largely attributed to lower volumes from key customers and decreased activity in related businesses, which also contributed to an overall 9.3% decline in consolidated sales. Despite attempts to manage costs, the adjusted EBITDA showed a notable decline of 34.8% largely due to increased raw material and operating costs, signaling challenges in maintaining profitability amidst declining sales volumes.
This aggregate rating is based on analysts' research of Koppers and is not a guaranteed prediction by Public.com or investment advice.
Koppers (KOP) Analyst Forecast & Price Prediction
Start investing in Koppers (KOP)
Order type
Buy in
Order amount
Est. shares
0 shares